The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: Protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context

BMJ Open

Volumn 3, Issue 8, 2013, Pages

  Kwakkenbos, Linda ^a,b   Jewett, Lisa R ^a,b   Baron, Murray ^a,c   Bartlett, Susan J ^c   Furst, Dan ^d   Gottesman, Karen ^e   Khanna, Dinesh ^f   Malcarne, Vanessa L ^g,h   Mayes, Maureen D ⁱ   Mouthon, Luc ^j,k   Poiraudeau, Serge ^j,k,l   Sauve, Maureen ^m   Nielson, Warren R ⁿ   Poole, Janet L ^o   Assassi, Shervin ⁱ   Boutron, Isabelle ^j,l,p   Ells, Carolyn ^c   Van Den Ende, Cornelia H M ^b   Hudson, Marie ^a,c   Impens, Ann ^q   Körner, Annett ^a,b,c   Leite, Catarina ^b,r   Maia, Angela Costa ^r   Mendelson, Cindy ^s   Pope, Janet ^t   Steele, Russell J ^a,c   Suarez Almazor, Maria E ⁱ   Ahmed, Sara ^c,u   Coronado Montoya, Stephanie ^a   Delisle, Vanessa C ^a,b   Gholizadeh, Shadi ^h   Jang, Yeona ^v   Levis, Brooke ^a,c   Milette, Katherine ^a,b   Mills, Sarah D ^h   Razykov, Ilya ^a,b   Fox, Rina S ^h   Thombs, Brett D ^a,b,c,d   more..

^a MCGILL UNIVERSITY   (Canada)

^b Department of Psychiatry ^*  (Belgium)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Scleroderma Foundation   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g SAN DIEGO STATE UNIVERSITY   (United States)

^h SAN DIEGO STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k Assistance Publique Hôpitaux de Paris ^*  (France)

^l INSERM   (France)

^m Scleroderma Society of Ontario   (Canada)

ⁿ ST JOSEPH S HEALTH CENTRE   (Canada)

^o UNIVERSITY OF NEW MEXICO   (United States)

^p HÔTEL DIEU   (France)

^q MIDWESTERN UNIVERSITY   (United States)

^r UNIVERSITY OF MINHO   (Portugal)

^s UNIVERSITY OF NEW MEXICO   (United States)

^t UNIVERSITY OF WESTERN ONTARIO   (Canada)

^u MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^v MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; DISABILITY; FEASIBILITY STUDY; HEALTH STATUS; HUMAN; INTERVENTION STUDY; OUTCOME ASSESSMENT; PSYCHOSOCIAL CARE; PSYCHOSOCIAL REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; REHABILITATION CENTER; SCLERODERMA PATIENT CENTERED INTERVENTION NETWORK; SELF CARE; STUDY DESIGN; SYSTEMIC SCLEROSIS;

EID: 84885358550     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003563     Document Type: Article

References (54)

1. Canadian Medical Association. Health care transformation in Canada. 2010. http://www.cma.ca/multimedia/CMA/Content-Images/Inside-cma/Advocacy/HCT/HCT- 2010report-en.pdf
2. Stewart M. Towards a global definition of patient centred care. BMJ 2001;322:444-5.
3. Lewis S. Patient-centered care: an introduction to what it is and how to achieve it. A discussion paper for the Saskatchewan Ministry of Health. 2009. http://www.health.gov.sk.ca/Default.aspx?DN=49372758-a388-4e95-8fe2-043c18362458
4. Ells C, Hunt MR, Evans JC Relational autonomy as an essential component of patient-centered care. Int J Fem Approaches Bioeth 2011;4:79-101.
5. Multidisciplinary care for patients with rheumatic and musculoskeletal diseases: The Rheumatology Health Care Team. http://www.rheumatology.org/ practice/clinical/position/multidisciplinaryCare.pdf
6. Reimann A, Bend J, Dembski B. [Patient-centred care in rare diseases. A patient organisations' perspective]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007;50:1484-93.
7. National Institutes of Health Office of Rare Diseases Research http://rarediseases.info.nih.gov/RareDiseaseList.aspx?PageID=1
8. Christian BJ, D'Auria JP. Building life skills for children with cystic fibrosis: effectiveness of an intervention. Nurs Res 2006;55:300-7. (Pubitemid 44412902)
9. Coyne JC, Thombs BD, Hagedoorn M. Ain't necessarily so: review and critique of recent meta-analyses of behavioral medicine interventions in health psychology. Health Psychol 2010;29:107-16.
10. Kraemer HC, Gardner C, Brooks J.O., et al Advantages of excluding underpowered studies in meta-analysis: inclusionist versus exclusionist viewpoints. Psychol Methods 1998;3:23-31.
11. Kraemer HC, Mintz J, Noda A., et al Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry 2006;63:484-9.
12. Thabane L, Ma J, Chu R., et al A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1.
13. Van Teijlingen E.R., Rennie AM, Hundley V, et al The importance of conducting and reporting pilot studies: the example of the Scottish Births Survey. J Adv Nurs 2001;34:289-95. (Pubitemid 33612936)
14. Goodridge D, Hutchinson S, Wilson D., et al Living in a rural area with advanced chronic respiratory illness: a qualitative study. Prim Care Respir J 2011;20:54-8.
15. Weinert C, Cudney S, Comstock B., et al Computer intervention impact on psychosocial adaptation of rural women with chronic conditions. Nurs Res 2011;60:82-91.
16. Thombs BD, Van Lankveld W, Bassel M, et al Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res (Hoboken) 2010;62:1181-9.
17. Kowal-Bielecka O., Landewe R, Avouac J., et al EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.
18. Seibold J. Scleroderma. In: Harris ED, Budd RC, Firestein GS, et al. eds. Kelley's textbook of rheumatology. Philadelphia: Elsevier, 2005:1279-308.
19. Wigley FM, Hummers LK Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS. eds Rheumatology. 3rd edn. Philadelphia: Mosby, 2003:1463-80.
20. Merkel PA, Herlyn K, Martin R.W., et al Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 2002;46:2410-20.
21. Ntoumazios SK, Voulgari PV, Potsis K, et al Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 2006;36:173-81. (Pubitemid 44767593)
22. Chifflot H, Fautrel B, Sordet C., et al Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37:223-35.
23. Bernatsky S, Joseph L, Pineau C.A., et al Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 2009;61:400-4.
24. Haythornthwaite JA, Heinberg LJ, McGuire L. Psychologic factors in scleroderma. Rheum Dis Clin North Am 2003;29:427-39. (Pubitemid 36765129)
25. Bassel M, Hudson M, Taillefer S.S., et al Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 2011;50:762-7.
26. Jewett LR, Haythornthwaite JA, Thombs BD Psychosocial issues and care for patients with systemic sclerosis. In: Varga J, Denton CPWigley FM. eds Scleroderma: frompathogenesis to comprehensive management. New York: Springer, 2012:641-8.
27. Jewett LR, Hudson M, Thombs BD A 38-year-old woman with elevated muscle enzymes, Raynaud's phenomenon and positive anti-topoisomerase I antibody: is she depressed? In: Silver RM, Denton CP. eds Case studies in systemic sclerosis. New York: Springer, 2011:273-80.
28. Thombs BD, Jewett LR, Assassi S, et al New directions for patient-centered care in scleroderma: the Scleroderma Patient-centered Intervention Network. Clin Exp Rheum 2012;30:23-9.
29. Cuijpers P, Donker T, Johansson R, et al. Self-guided psychological treatment for depressive symptoms: a meta-analysis. PLoS ONE 2011;6:e21274.
30. Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials. Med J Aust 2010;192:S4-11.
31. Donker T, Griffiths KM, Cuijpers P, et al. Psychoeducation for depression, anxiety and psychological distress: a meta-analysis. BMC Med 2009;7:797015-779.
32. Van der Vaart R, Repping-Wuts H, Drossaert CH, et al. Needs for online information and support of patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2013;65:594-600.
33. Relton C, Torgerson D, O'Cathain A, et al Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial," design. BMJ 2010;340:c1066.
34. Zwarenstein M, Treweek S, Gagnier J.J., et al Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
35. Ross S, Grant A, Counsell C., et al Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143-56. (Pubitemid 29535414)
36. Torgerson DJ, Torgerson CJ Designing randomised trials in health, education, and the social sciences: an introduction. Palgrave Macmillan, 2008.
37. Hinchcliff M, Beaumont JL, Thavarajah K, et al Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form. Arthritis Care Res (Hoboken) 2011;63:1620-8.
38. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91. (Pubitemid 27494658)
39. Kroenke K, Strine TW, Spitzer R.L., et al The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114:163-73.
40. Kroenke K, Spitzer RL, Williams J.B., et al The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010;32:345-59.
41. Razykov I, Hudson M, Baron M., et al The utility of the PHQ-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2013;65:753-8.
42. Lawrence JW, Heinberg LJ, Roca R, et al Development and validation of the satisfaction with appearance scale: assessing body image among burn-injured patients. Psychol Assess 1998;10:64-70. (Pubitemid 28183792)
43. Jewett LR, Hudson M, Haythornthwaite J.A., et al Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Arthritis Care Res (Hoboken) 2010;62:1779-86.
44. Heinberg LJ, Kudel I, White B., et al Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted satisfaction with appearance scale. Body Image 2007;4:79-86.
45. Duruoz MT, Poiraudeau S, Fermanian J., et al Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 1996;23:1167-72.
46. Lorig KR, Sobel DS, Ritter P.L., et al Effect of a self-management program on patients with chronic disease. Eff Clin Pract 2001;4:256-62.
47. Donovan J, Mills N, Smith M., et al Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ 2002;325:766-70.
48. Hewitt CE, Torgerson DJ, Miles JN Is there another way to take account of noncompliance in randomized controlled trials? CMAJ 2006;175:347.
49. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res 2005;14:369-95. (Pubitemid 41300812)
50. Clinical Trials Registry. http://www.clinicaltrials.gov
51. Boutron I, Moher D, Altman D.G., et al Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. (Pubitemid 351665487)
52. Boutron I, Moher D, Altman D.G., et al Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008;148:W60-6.
53. Draft policy on access to CIHR-funded research output. http://www.cihr-irsc.gc.ca/e/32326.html
54. Taillefer SS, Bernstein J, Schieir O., et al Canadian scleroderma patient survey of health concerns and research priorities: an initiative of the Scleroderma Society of Canada and the Canadian Scleroderma Research Group. Report. Montréal, 2010.